Meneses A - Search Results

1

A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma.

Dueñas-Gonzalez A, Verastegui E, Lopez-Graniel C, Gonzalez A, Mota A, Barrera-Franco JL, Meneses A, Chanona J, de la Garza J, Chavez-Blanco A, Hadden JW. Dueñas-Gonzalez A, et al. Among authors: meneses a. Int Immunopharmacol. 2002 Jun;2(7):1007-16. doi: 10.1016/s1567-5769(02)00048-6. Int Immunopharmacol. 2002. PMID: 12188025

2

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.

Meneses A, Verastegui E, Barrera JL, de la Garza J, Hadden JW. Meneses A, et al. Int Immunopharmacol. 2003 Aug;3(8):1083-91. doi: 10.1016/S1567-5769(03)00017-1. Int Immunopharmacol. 2003. PMID: 12860165

3

A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.

Verastegui E, Barrera JL, Zinser J, Del Rio R, Meneses A, De La Garza J, Hadden JW. Verastegui E, et al. Among authors: meneses a. Int J Immunopharmacol. 1997 Nov-Dec;19(11-12):619-27. doi: 10.1016/s0192-0561(97)00059-3. Int J Immunopharmacol. 1997. PMID: 9669202 Clinical Trial.

4

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck.

Hadden J, Verastegui E, Barrera JL, Kurman M, Meneses A, Zinser JW, de la Garza J, Hadden E. Hadden J, et al. Among authors: meneses a. Int Immunopharmacol. 2003 Aug;3(8):1073-81. doi: 10.1016/S1567-5769(03)00029-8. Int Immunopharmacol. 2003. PMID: 12860164 Clinical Trial.

5

Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery.

Meneses A, Verastegui E, Barrera JL, Zinser J, de la Garza J, Hadden JW. Meneses A, et al. Arch Pathol Lab Med. 1998 May;122(5):447-54. Arch Pathol Lab Med. 1998. PMID: 9593347 Clinical Trial.

6

Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.

Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW. Barrera JL, et al. Among authors: meneses a. Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51. doi: 10.1001/archotol.126.3.345. Arch Otolaryngol Head Neck Surg. 2000. PMID: 10722007 Clinical Trial.

7

Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.

Verastegui E, Morales R, Barrera JL, Müeller A, Guzman B, Meneses A, Alfaro G. Verastegui E, et al. Among authors: meneses a. Clin Immunol. 2002 Jan;102(1):37-47. doi: 10.1006/clim.2001.5130. Clin Immunol. 2002. PMID: 11781066

8

Non-Hodgkin's lymphomas in Mexico. A clinicopathological and molecular analysis.

Ortega V, Verastegui E, Flores G, Meneses A, Ocadiz R, Alfaro G. Ortega V, et al. Among authors: meneses a. Leuk Lymphoma. 1998 Nov;31(5-6):575-82. doi: 10.3109/10428199809057617. Leuk Lymphoma. 1998. PMID: 9922048

9

Primary B cell lymphoma of the rectum in a patient coinfected with HIV-1 and HTLV-I.

Verástegui E, Ortega V, Soler C, Lazo de la Vega S, Ocádiz R, Meneses A, Reynoso E, Alfaro G. Verástegui E, et al. Among authors: meneses a. Rev Invest Clin. 1992 Jul-Sep;44(3):387-92. Rev Invest Clin. 1992. PMID: 1283227

10

Treatment outcomes and prognostic factors in mexican patients with endometrial carcinoma with emphasis on patients receiving radiotherapy after surgery: an institutional perspective.

Flores C, Mariscal C, Celis A, Balcázar NM, Meneses A, Mohar A, Mota A, Trejo E. Flores C, et al. Among authors: meneses a. ISRN Oncol. 2012;2012:178051. doi: 10.5402/2012/178051. Epub 2012 May 17. ISRN Oncol. 2012. PMID: 22675641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters